SCARB2
Reactivité: Humain, Souris, Rat
WB, IHC (p), EIA
Hôte: Lapin
Polyclonal
unconjugated
Indications d'application
ELISA (1:4000) Western Blot (0.1-0.3 μg/mL) The optimal working dilution should be determined by the end user.
Restrictions
For Research Use only
Format
Liquid
Concentration
0.5 mg/mL
Buffer
In 0.5 mg/mL Tris saline, pH 7.3 (0.02 % sodium azide, 0.5 % BSA)
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
-20 °C
Stockage commentaire
Store at -20°C. Aliquot to avoid repeated freezing and thawing.
Li, Fan, Jin, Su, An, Xu, Sun, Zhang, Meng, Gao, Kong, Jiang: "Establishment of cell lines with increased susceptibility to EV71/CA16 by stable overexpression of SCARB2." dans: Virology journal, Vol. 10, pp. 250, (2013) (PubMed).
Berkovic, Dibbens, Oshlack, Silver, Katerelos, Vears, Lüllmann-Rauch, Blanz, Zhang, Stankovich, Kalnins, Dowling, Andermann, Andermann, Faldini, DHooge, Vadlamudi, Macdonell, Hodgson, Bayly, Savige et al.: "Array-based gene discovery with three unrelated subjects shows SCARB2/LIMP-2 deficiency causes myoclonus epilepsy and glomerulosclerosis. ..." dans: American journal of human genetics, Vol. 82, Issue 3, pp. 673-84, (2008) (PubMed).
Antigène
SCARB2
(Scavenger Receptor Class B, Member 2 (SCARB2))